FLGR-242 30mg — Vial Spec, Reconstitution Math & COA

FLGR-242 30mg Vial Overview & Laboratory Target Audience

A 30mg vial of FLGR-242 contains 30 milligrams of highly purified, lyophilized synthetic peptide engineered for in vitro and preclinical laboratory research. FLGR-242 is investigated in molecular biology protocols focused on transforming growth factor-beta (TGF-β) superfamily signaling, specifically targeting pathways involved in skeletal muscle protein turnover, cellular differentiation, and myostatin (GDF-8) inhibition mechanisms.

This high-yield 30mg format is primarily specified by institutional research teams, contract research organizations (CROs), and high-throughput analytical laboratories conducting multi-well assays or extended animal model studies. Purchasing a 30mg single-vial mass format minimizes batch-to-batch reconstitution variation across extensive testing runs compared to utilizing multiple lower-dose vials. Principal investigators evaluating high-mass options can review standard catalog availability for FLGR-242 or explore our broader library of all research peptides for complementary experimental reagents.

Reconstitution Mathematics: Volumetric Calculations for 30mg Mass

Accurate reconstitution of 30mg lyophilized FLGR-242 requires precise volumetric measurements based on the desired target concentration for specific assay protocols. Because 30mg represents a relatively large peptide mass, selecting the appropriate volume of sterile diluent—such as Bacteriostatic Water (0.9% benzyl alcohol) or Sterile 0.9% Sodium Chloride—is critical to ensure full solubility and optimal working viscosity.

Below are the standardized concentration yields based on common diluent reconstitution volumes:

• 1.0 mL Diluent Volume: Reconstituting 30mg of FLGR-242 with 1.0 mL of diluent yields a highly concentrated solution of 30.0 mg/mL (30.0 µg/µL). This high-density working stock is ideal for master stock preparation intended for subsequent micro-aliquoting.

• 2.0 mL Diluent Volume: Adding 2.0 mL of diluent results in a final stock concentration of 15.0 mg/mL (15.0 µg/µL). This intermediate concentration provides enhanced pipetting accuracy for medium-volume enzymatic or receptor binding assays.

• 3.0 mL Diluent Volume: Diluting the 30mg cake with 3.0 mL of liquid yields a concentration of 10.0 mg/mL (10.0 µg/µL). This standard concentration simplifies serial dilution calculations for multi-well plate loading.

To quickly verify custom reconstitution volumes and micro-liter dosages across varying stock concentrations, laboratory technicians should utilize our digital reconstitution calculator prior to liquid handling.

Aliquoting Strategies & Freeze-Thaw Prevention Protocols

Repeated freeze-thaw cycles significantly accelerate peptide degradation via molecular shear stress, aggregation, and peptide backbone cleavage. When handling a 30mg yield of reconstituted FLGR-242, establishing a standardized aliquoting procedure immediately following initial dissolution is essential for preserving structural integrity across prolonged trial periods.

Once the lyophilized cake is fully dissolved by gentle swirling—never vortexing—the master solution should be divided into single-use micro-centrifuge tubes based on projected assay consumption. For instance, creating thirty 100 µL aliquots from a 3.0 mL reconstituted batch (at 10 mg/mL) ensures that each individual working tube contains 1 mg of active peptide. These sub-aliquots should be flash-frozen and stored at -20°C or -80°C until needed. Once a working aliquot is thawed for an assay protocol, any remaining unused solution should be stored at 4°C and used within 24 to 48 hours rather than refrozen.

Structural Profile & Preclinical Mechanism Studies

FLGR-242 is an engineered peptide derivative designed to interact with negative regulators of muscle tissue growth. In preclinical models, compounds within this structural class are evaluated for their capacity to modulate activin receptor type IIB (ActRIIB) binding dynamics and neutralize myostatin signaling cascades.

In vitro data indicate that FLGR-242 binds selectively to circulating myostatin (GDF-8) proteins, inhibiting their downstream interaction with cellular receptors. In rodent muscle cell culture models, this regulatory blockade alters Smad2/3 phosphorylation levels, preventing the activation of gene transcription pathways that typically induce muscle protein degradation. Researchers track these molecular pathways to understand hypertrophy regulation, protein synthesis velocity, and cellular recovery kinetics under simulated physiological stress conditions.

Comparative Analysis: FLGR-242 vs. Related Myostatin Inhibitors

When designing pathways for myostatin inhibition and muscular adaptation research, investigators often compare FLGR-242 against other key regulatory peptides in the TGF-β receptor axis. Understanding the distinct affinity profiles and molecular sizes of these compounds helps clarify experimental selection.

For example, follistatin 315 is a naturally occurring glycoprotein that binds broadly to activin A and myostatin, whereas FLGR-242 is a targeted synthetic peptide developed for enhanced specificity. Similarly, ace-031 operates as a soluble fusion protein decoy receptor (ActRIIB-Fc), sequestering myostatin before it reaches membrane-bound cell receptors. While soluble fusion proteins like ACE-031 possess high molecular weights and complex glycosylation requirements, smaller synthetic constructs like FLGR-242 offer distinct advantages in solubility, synthesis consistency, and targeted receptor binding studies in cell-free or cell-culture assay environments.

Quality Assurance: HPLC, Mass Spectrometry & Endotoxin Standards

PX1 Research enforces strict quality control standards for every production batch of FLGR-242. High-Performance Liquid Chromatography (HPLC) testing is performed to confirm chemical purity levels equal to or exceeding 98.0%. Liquid Chromatography-Mass Spectrometry (LC-MS) analysis further confirms the precise molecular mass and primary amino acid sequence matching theoretical predictions.

In addition to structural purity, endotoxin contamination presents a critical variable in cell culture and animal model research. High endotoxin levels induce unwanted inflammatory cascades that skew cellular readings and experimental outcomes. PX1 Research subjects all peptide lots to Chromogenic Recombinant Cascade Reagent endotoxin testing, ensuring limits remain strictly below 0.01 EU/mg. Investigators can access and download lot-matched testing documentation via our centralized COA search engine.

Storage Parameters: Lyophilized Powder vs. Liquid Reconstitution

Maintaining proper environmental controls is critical for preserving the bioactivity of FLGR-242 over time. Lyophilized peptide powder is inherently stable but remains susceptible to thermal degradation, atmospheric humidity, and light exposure.

• Unreconstituted Dry Powder: Store at -20°C for up to 24 months. For long-term archival storage (exceeding 2 years), keep vials stored at -80°C in a desiccated container protected from light exposure.

• Reconstituted Liquid Solution: Once reconstituted with a sterile bacteriostatic diluent, store the solution at 2°C to 8°C for short-term active use (up to 28 days). If reconstituted with sterile water without preservatives, use within 24 hours at refrigerated temperatures. For extended storage of reconstituted solutions, store aliquoted tubes at -20°C or -80°C for up to 3 to 6 months.

Selecting the Optimal Format: 30mg vs. Standard Catalog Sizes

Choosing between a 30mg vial and smaller standard options (such as 2mg, 5mg, or 10mg vials) depends directly on project scale, dosing frequency, and budget efficiency. The 30mg format offers significant cost per milligram efficiency for institutional research groups conducting high-volume animal dosing or continuous cellular screens.

However, for smaller exploratory protocols or occasional analytical runs, lower mass vials may be preferable to minimize the storage period of reconstituted liquids. If PX1 Research does not list a standard off-the-shelf 30mg SKU for a specific item, researchers can readily order standard catalog sizes like the FLGR-242 product page format or request custom batch manufacturing and volumetric scaling through our dedicated wholesale program.

Laboratory Reconstitution Protocol & Handling Guidelines

To maximize stability and ensure complete peptide dissolution during laboratory preparation, adhere to the following analytical step-by-step protocol:

1. Equilibration: Remove the FLGR-242 vial from cold storage (-20°C) and allow it to equilibrate to room temperature for 20–30 minutes prior to reconstitution. This step prevents condensation from introducing excess moisture into the vial upon opening.

2. Sanitization: Clean the rubber stopper with a 70% isopropyl alcohol wipe and allow it to air-dry completely in a laminar flow hood.

3. Diluent Addition: Using a sterile analytical syringe, draw the calculated volume of diluent (e.g., 2.0 mL of Bacteriostatic Water). Direct the needle against the inner glass wall of the vial rather than shooting liquid directly onto the lyophilized cake.

4. Dissolution: Allow the diluent to absorb into the cake naturally. Gently roll and invert the vial between your hands until all lyophilized material is completely dissolved. Never shake or vortex the vial, as mechanical agitation causes protein denaturation and foaming.

5. Inspection: Visually inspect the solution under clear lighting. The reconstituted liquid must be fully transparent, clear, and free of visible particulates before pipetting into experimental assays.